S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
NASDAQ:ANIX

Anixa Biosciences - ANIX Stock Reddit Activity & Social Media Sentiment

$4.30
-0.08 (-1.83%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$4.24
$4.40
50-Day Range
$3.86
$4.94
52-Week Range
$2.50
$6.25
Volume
25,777 shs
Average Volume
52,987 shs
Market Capitalization
$132.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.50

Reddit Posts Over Time



View Trending Reddit Stocks

Media Mentions Over Time



View Trending Media Stocks

MarketBeat New Follows Over Time



View Trending Stocks on MarketBeat

MarketBeat Searches Over Time



Recieve ANIX News and Ratings via Email

Sign-up to receive the latest news and ratings for Anixa Biosciences and its competitors with MarketBeat's FREE daily newsletter.

ANIX Social Media Mentions

Recent ANIX Stock Reddit Threads

March 27th, 2023  10:28 AM  |  cotrusteebrochtq21 |  smallstreetbets
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine

Whats up, Reddit? Im not a big science person, but I saw this article about Anixa Biosciences and thought it was pretty cool. Theyre working on a vaccine for breast cancer, which is a big deal considering how many people are affected by the disease. Apparently theyre …

March 22nd, 2023  12:48 PM  |  digamymagadisg88 |  investing_discussion
Anixa Biosciences, Inc. (ANIX) - In a great position moving through 2023!

I am always on the lookout for exciting BioTech companies that have the potential to provide value to society. I recently came across Anixa Biosciences (ANIX) and was instantly intrigued by their dedication to develop first-in-class treatments to prevent and treat unmet needs in oncology …

March 22nd, 2023  12:47 PM  |  digamymagadisg88 |  investing_discussion
Anixa Biosciences (ANIX): Meeting Unmet Market/Global Needs

I am always on the lookout for exciting BioTech companies that have the potential to provide value to society. I recently came across Anixa Biosciences (ANIX) and was instantly intrigued by their dedication to develop first-in-class treatments to prevent and treat unmet needs in oncology …

March 14th, 2023  12:21 PM  |  TheSpectacularOracle |  smallstreetbets
NEWS: Axia Biosciences carrying no accounts at SVB

Looking like the trend here today is a lot of companies having no accounts linked to the closed banks at all. What are your thoughts/opinions? throw them in the comment section below. Anixa Biosciences, Inc. (NASDAQ: ANIX), a leading biotechnology company focused on …

March 7th, 2023  11:57 AM  |  digamymagadisg88 |  trakstocks
Unique company on my radar - Anixa Biosciences (ANIX)

I am always on the lookout for exciting BioTech companies that have the potential to provide value to society. I recently came across Anixa Biosciences (ANIX) and was instantly intrigued by their dedication to develop first-in-class treatments to prevent and treat unmet needs in oncology …

February 27th, 2023  4:41 PM  |  digamymagadisg88 |  investing_discussion
Anixa Biosciences (ANIX) Making big moves in 2023!

I am always on the lookout for exciting BioTech companies that have the potential to provide value to society. I recently came across Anixa Biosciences (ANIX) and was instantly intrigued by their dedication to develop first-in-class treatments to prevent and treat unmet needs in oncology …

February 27th, 2023  4:40 PM  |  digamymagadisg88 |  WallStreetbetsELITE
In depth analysis on Anixa Biosciences (ANIX)

I am always on the lookout for exciting BioTech companies that have the potential to provide value to society. I recently came across Anixa Biosciences (ANIX) and was instantly intrigued by their dedication to develop first-in-class treatments to prevent and treat unmet needs in oncology …

February 27th, 2023  4:39 PM  |  digamymagadisg88 |  StocksAndTrading
Anixa Biosciences (ANIX) - Crazy cash on hand: In a position to excel this year!

I am always on the lookout for exciting BioTech companies that have the potential to provide value to society. I recently came across Anixa Biosciences (ANIX) and was instantly intrigued by their dedication to develop first-in-class treatments to prevent and treat unmet needs in oncology …

February 6th, 2023  4:03 PM  |  digamymagadisg88 |  trakstocks
Excited for the future with Anixa Biosciences, Inc. (ANIX)

I am always on the lookout for exciting BioTech companies that have the potential to provide value to society. I recently came across Anixa Biosciences (ANIX) and was instantly intrigued by their dedication to develop first-in-class treatments to prevent and treat unmet needs in oncology …

January 19th, 2023  5:47 PM  |  digamymagadisg88 |  StocksAndTrading
Quick Synopsis on Anixa Biosciences (ANIX) Check this out!

I am always on the lookout for exciting BioTech companies that have the potential to provide value to society. I recently came across Anixa Biosciences and was instantly intrigued by their dedication to develop first-in-class treatments to prevent and treat unmet needs in oncology …

January 19th, 2023  5:47 PM  |  digamymagadisg88 |  WallStreetbetsELITE
A Deep Dive Into Anixa Biosciences, Inc. (ANIX)

I am always on the lookout for exciting BioTech companies that have the potential to provide value to society. I recently came across Anixa Biosciences and was instantly intrigued by their dedication to develop first-in-class treatments to prevent and treat unmet needs in oncology …

January 19th, 2023  5:46 PM  |  digamymagadisg88 |  investing_discussion
A Brief Look Into Anixa Biosciences, Inc. (ANIX)

I am always on the lookout for exciting BioTech companies that have the potential to provide value to society. I recently came across Anixa Biosciences and was instantly intrigued by their dedication to develop first-in-class treatments to prevent and treat unmet needs in oncology …

This page (NASDAQ:ANIX) was last updated on 3/31/2023 by MarketBeat.com Staff